R. Ahiabor

A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer.

D. Dearnaley, R. Huddart, C. Parker, 2015, European urology.

System issues: Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay

F. Staedtler, F. Mantovani, E. Perentes, 1996 .

764PDA RANDOMISED PHASE II TRIAL OF DEXAMETHASONE VERSUS PREDNISOLONE IN CASTRATION RESISTANT PROSTATE CANCER.

D. Dearnaley, R. Huddart, C. Parker, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.

F. Staedtler, F. Mantovani, E. Perentes, 1996, Environmental and molecular mutagenesis.

A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer.

D. Dearnaley, R. Huddart, C. Parker, 2015, European Urology.

System issues: Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay

F. Staedtler, F. Mantovani, M. Robinson, 1996 .